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CASE REPORT

ANAESTHETIC MANAGEMENT OF A PATIENT WITH
PHAEOCHROMOCYTOMA AND UNCONTROLLED BLOOD
PRESSURE
Ursula Chohan and Fazal H Khan

ABSTRACT: Anaesthetic management of phaeochromocytoma includes pre·operative preparation, intraoperative control and
avoidance of drugs that cause hypotension or hypertension. A case of 46-year old male, with phaeochromocytoma is presented
here highlighting issues in anaesthetic management.
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INTRODUCTION
Phaeochromocytomas are rare catecholamine secreting
tumours of the adrenal medul1a 1 • The incidence varies from
0.1% to 0.8% in the hypertensive population1 • Majority of
these tumours (85-90%) are located on adrenal gland.
Approxi-mately 10% of adult patients and 25% of paediatric
patients have bilateral tumours. Almost 90% of the tumours
are found in the abdomen. Remaining 5% are found anywhere along the sympathetic tissue from the neck to the
inguinal ligament. Biochemical tests and noninvasive localising methods are essential for the definite diagnosis of
phaeochromocytoma. Surgical removal of the tumour is the
only definite therapy with low morbidity and mortality. The
initial successful operations for the removal of phaeochromocytoma were performed by Cesar Raux and CH Mayo, in
19263.4.
In this report we describe a successful anaesthetic management of a patient with phaeochromocytoma.

CASE REPORT
A 46 years old male, diagnosed case of phaeochromocytoma
with paroxysmal hypertension, was admitted to control his
recent symptom of breathlessness. He is an insulin dependent
diebetic, and a heavy smoker. He also had one episode of
chest pain, which radiated to the left arm, about 6 months
ago.
On examination there were bilateral rhonchi and tenderness
in both hypochondriac regions. Electrocardiogram had evidence of antero septal infarct. Ultrasound abdomen showed a
non-visible left kidney and hypertrophied right kidney with a

4 x 4.5 em mass at the upper pole. CT abdomen showed right
adrenal mass with absent left kidney and a right sided pleural
effusion.
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Hypertension
The urinary catecho}amines were 2256 mg/24 hours (range

10-270), urine VMA was 4340mg/24 hours (range 1.9-9.8),
serum cortisol was 23.9 (3.25) and S.DHEA S04 was 35.8
(range 80-560).
Echocardiography showed left ventricular hypertrophy,
severe left ventricular dysfunction with ejection fraction of
16%. The septum and the apex of the heart were dyskinetic.
The coronary angiography revealed single vessel disease
involving left circumflex artery. The patient was discharged
home after the control of symptoms.
The patient had a regular follow up, and repeat investigations after one month of treatment showed an ejection fraction of 43%. Moderate fluctuations in the control of blood
pressure were observed and patient was admitted to the
intensive care unit for further management of fluctuating
blood pressure prior to the surgical removal of tht: tumour.
Preoperatively, most of the symptoms had ameliorated.
Ortho-static hypotension was within the recommt:nded

range of 80/45mm Hg, although there were episodes of fluctuating blood pressure. The physician incharge of the case
suggested to go ahead with surgery as further control of
blood pressure was not possible.
On the morning of surgery, the patient was premedicated
with morphine lOmg intramuscular, midazolam 7.5 mg orally
alongwith his antihypertensive medications. This resulted in

a drop of blood pressure to 80/50 mmHg. Following a fluid
bolus of 500 ml, the B.P. came up to 90/60 mmHg. Patient
was shifted to O.R. for monitoring. Arterial line was established in the left radial artery, for invasive blood pressur-e

monitoring. Blood pressure ranged between 85-95/55-60
mmHg. A 1000 ml of fluid was infused, that resulted in blood
pressure of 100/60 mmHg but patient develop-ed tachycardia,
with a heart rate of 120-130/min. A swan ganz catheter was
inserted at this stage. Initial central venous pressure was 3 em
of water, for which 2.5L fluid was given and central venous
pressure came upto 6 em of water, cardiac out put was 6.5 L
and systemic vascular resistance was 550.
Nordarenaline infusion at the rate of 0.02 ug/kg/min was
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ltarted to improve the ~ystemic vascular resistance and thereliter blood pressure rose to 120-130/65-75, heart rate 90/min,
central venous pressure came upto 10 em of water, cardiac
out put was lOL/min and the systemic vascular resistance
Was 650. The Noradrenaline infusion was stopped before
induction.
Induction of anaestheia was carried out with midazolam.
thiopentone, vecuronium, and maintained on isoflurane,
Vecuronium and morphine. Intra operatively patient
remained stable until the manipulation of tumour when the
B.P. shot up from 120/70 to 200-300/100-160 mm of Hg. sodi1Um nitroprusside (0.3-6ug/kg/min) infusion was started to
:control the blood pressure. At time boluses of 50-lOOug were
~ven. With this treatment blood pressure remained fluctuatmgbetween 250/120 to 130/75mmHg.
The resection time was 75 minutes. Following resection of
the tumor the blood pressure dropped to 90/60 mm Hg. Nor
adrenaline infusion was restarted at 0.04-0.1ug/kg/min and
When the blood pressure reached the base line, dose was
decreased to 0.02ug/kg/min.
After completion of surgery, the patient was extubated and
shifted to the ICU with noradrenaline infused at a rate of 0.030.lug/kg/min. The patient had one episode of hypotension
during the 1st 24 hours, which was corrected by increasing
noradrenaline infusion. The patient remained stable during
the 2nd and 3rd post-operative day. On the 3rd post-operative
day noradrenaline infusion was discontinued. The heamodynamic parameters of the patient at this stage were as follows,
blood pressure of 130/70, cardiac index was 3.5, systemic vascular resistance was 925 Dynes/sec/cm 5, central venous pressure 10 em water, PAP 25/15 swan ganz catheter and arterial
line were removed at this stage, patient shifted out of the ICU
the following day.

l

DrscussroN
Phaeochromocytoma is rare catecholamine secreting
tumour. Due to continuous or phasic secretion of catecholamine from the tumour, patients present with hypertensive crisis, episodic or sustained hypertension or arrhythmia5 •
Surgical removal of identified lesions should be performed
under controlled conditions and after sufficient preparation of
the patient.
Our patient was managed pre-operatively with Terazocin,
Tenormin and Rani tee. Terazocin was selected for our patient,
because of ischaemic heart disease along with phaeochromocytoma. Terazocin in a dose ranging from 1-20mg I day is as
effective as Prazocin, as it selectively blocks postsynaptic alpha lreceptors, it does not produce reflex tachycardia and
has a shorter duration of action, thereby permitting more
rapid adjustment of dosage and decreasing the duration of
post-operative hypotension. Beta blockade for the control of
preoperative hypertension is only recommended, once the
alpha 1 adrenergic blockade has been effectively achieved or
in patients with persistent tachycardia or arrhythmias. Other
agents recommended for the control preoperative hypertension are calcium channel blockers6 • These agents reduces
blood pressure by inhibiting norepinephrine mediated transmembrane calcium influx in vascular smooth muscle and not
by decreasing catecholamines synthesis in tumours 7 • The
main advantage of these agents is that they do not produce
over shoot hypotension or orthostatic hypotension and can
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be safely used in normotensive patients who have occasional
episodes of paroxysmal hypertension.
The proposed criteria for adequate preoperative preparation
is to achieve a supine arterial pressure 8 not greater than
160/90 mmHg, orthostatic hypotension not exceeding 80/45
mmHg, electrocardiogram free of ST -segments or T warve
changes for atleast 2 weeks and no more than one premature
ventricular contraction every 5 minutes. We did try to follow
this criteria but the control of blood pressure was difficult
even after maximum doses of antihypertensive drug, after
admission in ICU. As the physician incharge of the case insisted that further control of blood pressure was not possible,
therefore, the patient was scheduled for surgery. The importance of adequate volume expansion and proper blood pressure control was further highlighted by the fact that our
patient did drop his blood pressure on the morning of
surgery after receiving premedication and antihypertensive
drugs. This hypotensive episode was treated with non-adrenaline as 2 L of rapid fluid infusion failed to improve the blood
pressure. This hypotensive episode before induction was
treated by using swan ganz catheter for haemodynamic monitoring. We had to use noradrenaline in our patient, as even 2
L of fluid transfusion did not bring the blood pressure up. We
therefore, recommend that it is beneficial to have an invasive
arterial pressure monitoring and a PA catheter in place in all
such patients before induction to control any haemodynamic
instability during induction, maintenance or following
removal of the tumour.
Our patient did have a hypertensive crisis during surgical
manipulation of the tumour and this was controlled with the
use of sodium nitropruside and increasing the Isoflurane to
3%. Hypertension during manipulation of the tumor is due to
the release of catecholamine and it is treated by nitropruside
infusion in a dose of 0.5-1ug/kg/min. Nitroprusside is a
direct acting arteriolar dilating agent with a rapid onset and
short duration of action and therefore is helpful in cases like
these where there is a wide and rapid fluctuation in the blood
pressure. Our patient required much larger doses of sodium
nitroprusside to control his blood pressure intra-operatively.
This patient also had an episode of hypotension on removal
of the tumour, which was controlled by noradrenaline infusion at the rate of 0.04-0.1 ug/kg/min. This was continued
until the 3rd post-operative day. If the hypotension is persistent then one should rule out hypovolaemia, sudden haemorrhage or residual effects of preoperative alpha 1 adrenergic
blockade. Therefore we recommend initially giving large volumes of 1/V fluids and only then using noradrenaline infusion in such cases.
In conclusion, management of patients with phaeochromocytoma should focus on the better understanding of pathophysiology of phaeochromocytoma, better preoperative prepa. ration and intraoperative control, and avoidance of drugs that
causes hypotension or hypertension, use of invasive haemodynamic monitoring and prompt treatment of hypertensive and
hypotensive episodes as and when they occur.
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